Thyroid disease

Cancer Risks of Patients with Graves’ Disease Who Received Antithyroid Drugs as Initial Treatment: A Nationwide Population-Based Analysis

ThyroidPublished Retrospective cohort study

Authors' conclusion

In this large-scale population-based study, GD was associated with increased risks of biliary tract and pancreatic, prostate, ovarian, and thyroid cancers. The increased risk of thyroid cancer, particularly during the initial follow-up period, may be a surveillance effect.

Study context

Population
Adults aged >20 years with Graves' disease (GD) receiving antithyroid drugs (ATDs) as initial treatment and matched controls, National Health Information Database of South Koreamatched cohort
Participants
29,502 vs 57,173
Exposure
GD treated initially with ATDs vs matched controls
  • GDn = 29,502
  • Controln = 57,173reference
Outcome
Incidence of various types of cancers
Methodological detailsnationwide, population-based, age- and sex-matched controls
  • Nationwide
  • Population-based
  • Age- and sex-matched controls

Main finding

As reported in the abstract

Cancer risk by type · excluding first year of follow-up
GD vs ControlHazard ratio (CI)
Biliary tract and pancreatic cancers
1.41(1.24–1.60)
Thyroid cancer
15.51(12.29–19.57)
Prostate cancer
1.48(1.28–1.71)
Ovarian cancer
1.31(1.13–1.52)

Observational data: associations, not effects.

Further findings

OutcomeHR (CI)
Thyroid cancer risk, initial follow-up period · 1 to <2 yearsHigher than in follow-up >2 years19.35 (7.66–48.87)

Cancer risk with follow-up >5 years

Increased risk of these cancers persisted after >5 years of follow-up

Cancer risk excluding GD patients with subsequent RAI

Cancer risk estimates remained significant after excluding patients who underwent subsequent RAI

Original publication

Cancer Risks of Patients with Graves’ Disease Who Received Antithyroid Drugs as Initial Treatment: A Nationwide Population-Based Analysis. Thyroid. Published 3 September 2024. doi:10.1089/thy.2024.0178

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.